Indication
Hepatic coma
Hepatic coma represents the most severe, life-threatening stage (Grade IV) of hepatic encephalopathy, characterized by profound central nervous system depression, complete loss of consciousness, and unresponsiveness to external stimuli. Read more about Hepatic coma
15 drugs 14 manufacturers
Drugs that treat it
Common Hepatic coma therapies.
PAROMOMYCIN SULFATE
HUMATIN (paromomycin sulfate)
NEOMYCIN SULFATE
NEOMYCIN SULFATE
PAROMOMYCIN SULFATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHepatic coma represents the most severe, life-threatening stage (Grade IV) of hepatic encephalopathy, characterized by profound central nervous system depression, complete loss of consciousness, and unresponsiveness to external stimuli.
This neuropsychiatric complication primarily affects patients with acute liver failure, end-stage chronic liver disease or cirrhosis, or significant portosystemic shunting.
Pathophysiologically, severe hepatic dysfunction and the bypass of portal blood flow permit circulating neurotoxins—predominantly ammonia—to cross the blood-brain barrier.
This neurotoxic accumulation triggers astrocyte swelling, systemic and neuroinflammation, and impaired neurotransmission, which can culminate in cerebral edema, elevated intracranial pressure, and coma.
- nih.gov
Hepatic coma represents the most severe, life-threatening stage (Grade IV) of hepatic encephalopathy, characterized by profound central nervous system depression, complete loss of consciousness, and unresponsiveness to external stimuli
- nih.gov
Hepatic coma represents the most severe, life-threatening stage (Grade IV) of hepatic encephalopathy, characterized by profound central nervous system depression, complete loss of consciousness, and unresponsiveness to external stimuli This neuropsychiatric complication primarily affects patients with acute liver failure, end-stage chronic liver disease or cirrhosis, or significant portosystemic shunting
- mayoclinic.org
Hepatic coma represents the most severe, life-threatening stage (Grade IV) of hepatic encephalopathy, characterized by profound central nervous system depression, complete loss of consciousness, and unresponsiveness to external stimuli Pathophysiologically, severe hepatic dysfunction and the bypass of portal blood flow permit circulating neurotoxins—predominantly ammonia—to cross the blood-brain barrier
- nih.gov
This neuropsychiatric complication primarily affects patients with acute liver failure, end-stage chronic liver disease or cirrhosis, or significant portosystemic shunting Pathophysiologically, severe hepatic dysfunction and the bypass of portal blood flow permit circulating neurotoxins—predominantly ammonia—to cross the blood-brain barrier This neurotoxic accumulation triggers astrocyte swelling, systemic and neuroinflammation, and impaired neurotransmission, which can culminate in cerebral ede...
- nih.gov
This neuropsychiatric complication primarily affects patients with acute liver failure, end-stage chronic liver disease or cirrhosis, or significant portosystemic shunting
- nih.gov
Pathophysiologically, severe hepatic dysfunction and the bypass of portal blood flow permit circulating neurotoxins—predominantly ammonia—to cross the blood-brain barrier This neurotoxic accumulation triggers astrocyte swelling, systemic and neuroinflammation, and impaired neurotransmission, which can culminate in cerebral edema, elevated intracranial pressure, and coma
- nih.gov
This neurotoxic accumulation triggers astrocyte swelling, systemic and neuroinflammation, and impaired neurotransmission, which can culminate in cerebral edema, elevated intracranial pressure, and coma
Personalize your experience
Follow Hepatic coma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.